Deutsche Bank
HQL

Deutsche Bank’s abrdn Life Sciences Investors HQL Stock Holding History

Deutsche Bank’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-321
Closed -$5K – 5037
2016
Q2 		$5K Buy
321
+14
+5% +$258 ﹤0.01% 5003
2016
Q1 		$5K Hold
307
– – ﹤0.01% 4957
2015
Q4 		$7K Buy
307
+305
+15,250% +$7.57K ﹤0.01% 5004
2015
Q3 		$0 Hold
2
– – ﹤0.01% 5248
2015
Q2 		$0 Hold
2
– – ﹤0.01% 5390
2015
Q1 		$0 Hold
2
– – ﹤0.01% 5480
2014
Q4 		$0 Buy
2
+1
+100% +$24 ﹤0.01% 6222
2014
Q3 		$0 Hold
1
– – ﹤0.01% 5969
2014
Q2 		$0 Hold
1
– – ﹤0.01% 5945
2014
Q1 		$0 Hold
1
– – ﹤0.01% 5676
2013
Q4 		$0 Hold
1
– – ﹤0.01% 5517
2013
Q3 		$0 Hold
1
– – ﹤0.01% 5609
2013
Q2 		$0 Buy
+1
New +$18 ﹤0.01% 5349

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Deutsche Bank's HQL Position: Q3 2016 in Review

Deutsche Bank sold out of abrdn Life Sciences Investors (HQL) in Q3 2016, closing a stake of 321 shares — an estimated $5K sold.

Deutsche Bank first reported a position in HQL in Q2 2013 and held it in 13 quarters. The position peaked at $7K in Q4 2015. 45 funds tracked by Wall St. Rank hold HQL as of Q3 2016.

  • Deutsche Bank reported no remaining abrdn Life Sciences Investors position as of Q3 2016 after selling out during the quarter.
  • Deutsche Bank sold 321 abrdn Life Sciences Investors shares in Q3 2016, an estimated $5K.
  • Deutsche Bank first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 13 quarters.
  • Deutsche Bank's abrdn Life Sciences Investors position peaked at $7K in Q4 2015.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.